Company news

Syntara Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Pharmaxis Announces First Relaunch Sales of Aridol in USA

December 12, 2018

Pharmaxis AGM - CEO Presentation

November 22, 2018

LOX Inhibitor Program for Pancreatic Cancer Phase 1 Ready

November 19, 2018

Pharmaxis Releases Positive Results of Phase 1 Clinical Tria

November 14, 2018

Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor

October 10, 2018

FDA Factory Approval and Relaunch of Aridol in US Market

August 14, 2018

Capital Raising Presentation

August 6, 2018

Trading Halt Announcement - System Upgrade

August 5, 2018

Quarterly Shareholder Update - June 2018

July 26, 2018

LOXL2 Program Attracts Strong Partner Interest at BIO18

June 13, 2018

Quarterly Shareholder Update - March 2018

April 30, 2018

Pharmaxis Earns A$15 Million Milestone Payment

January 10, 2018

New Australian PBS Listing for Brocnhitol

January 1, 2018

Pharmaxis Acquires Control, Increases Stake in LOXL2 Program

December 13, 2017

Boehringer Initiating Phase 2a Study Diabetic Retinopathy

September 7, 2017

Antifibrotic LOXL2 Program Clears Preclinical Development

September 5, 2017

Boehringer Ingelheim Initiates Phase IIa Study in NASH

August 24, 2017

Positive Recommendation for Broader Bronchitol Access in Aus

August 18, 2017

Preliminary Final Report June 2017

August 10, 2017

Appendix 4C - quarterly June 2017

July 28, 2017

Pharmaxis Announces Results of Pivotal CF Clinical Trial

June 12, 2017

Pharmaxis Set to Generate Further Euro 10m Milestone Payment

May 14, 2017

Pharmaxis Appoints Chiesi as Bronchitol Distributor in Italy

May 8, 2017

Appendix 4C - quarterly cash flow

April 18, 2017

Quarterly Shareholder Update March 2017

April 17, 2017

Synairgen Collaboration Progress

March 12, 2017

Chairmans Address to Shareholders

November 29, 2016

Research Collaboration with Woolcock Institute

November 15, 2016

S&P DJ Indicies Announces March Quarterly Rebalance

November 7, 2016

Pharmaxis Announces Russian Approval for Bronchitol

September 26, 2016

Pharmaxis Completes Recruitment of CF Clinical Trial for US

July 14, 2016

Appendix 4C - quarterly March 2016

April 14, 2016

US FDA Accepts Bronchitol New Drug Application for Review

March 30, 2016

Quarterly Share Update - December 2015

February 11, 2016

Bronchitol Paediatric CF Trial Reports Postive Results

February 10, 2016

← Newer news releases

Decks

The 5 newest of 39 decks. Every deck is listed under its year.